Other

The novel GIP, GLP-1 and glucagon receptor agonist retatrutide delays gastric emptying.

Diabetes, obesity & metabolism · 1 Sept 2023

Record

Publication details

Authors
Urva S, O'Farrell L, Du Y, Loh MT, Hemmingway A, Qu H, Alsina-Fernandez J, Haupt A, Milicevic Z, Coskun T
Journal
Diabetes, obesity & metabolism
Publication date
1 Sept 2023
Publication type
Journal Article
Evidence type
Other
Relevance classification
Primary
PubMed ID
37311727
DOI
10.1111/dom.15167
Language
eng
Linked clinical trial
Not reported

Abstract

Abstract not reported by the source record.

Weekly briefing

The Retatrutide Report

The most important retatrutide clinical trial, research and regulatory developments, once a week.

No spam. Unsubscribe anytime. By subscribing, you agree to receive the Retatrutide Report by email. You can unsubscribe at any time. Privacy Policy.